Shares of DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $109.60 and last traded at $109.60, with a volume of 120 shares. The stock had previously closed at $100.26.
Analyst Ratings Changes
Separately, UBS Group downgraded shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.
Check Out Our Latest Research Report on DSRLF
DiaSorin Trading Up 9.3 %
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Read More
- Five stocks we like better than DiaSorin
- Investing in Construction Stocks
- Realty Income: An Anchor in Volatile Markets
- Profitably Trade Stocks at 52-Week Highs
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Ride Out The Recession With These Dividend Kings
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.
